A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
7 Hills Pharma, LLC
7 Hills Pharma, LLC
Memorial Sloan Kettering Cancer Center
DEKA Biosciences
Bristol-Myers Squibb
Cambridge University Hospitals NHS Foundation Trust
Bristol-Myers Squibb
Osaka University
University Hospital, Tours
Bristol-Myers Squibb